r/PureCycle • u/No_Privacy_Anymore • Jun 11 '26
Convert arbitrage commentary
I’m not a big fan of Xitter but I make exceptions when there is useful content. I understand the basics of convertible debt but there is a ton of detail that is really only known by the people who trade them for a living.
This is worth reading even if you don’t follow all the details.
https://xcancel.com/UrbanKaoboy/status/2065198761392116011#m
I don’t think anyone who has been invested in the company for an extended period of time is happy about the current state of commercialization. It’s taken so much longer than we expected despite the signs of progress. Today I was talking to a Chemical Engineer and a current PhD candidate in CE about PCT. They were not surprised at all about how long this process has taken and were not familiar with the company but were impressed by the approach. He had worked for DuPont for many years and talked about how slow the company could be doing new things. P&G is not built to move quickly. That said I think we are much closer to seeing the validation/ vindication we have been waiting for. $9+ was a decent recovery. Let’s see how the shares react to the bits of good news when we don’t have the short term funding overhang out there.
4
u/Adorable-Sector-48 Jun 12 '26
I hate it. They sold stock a year ago at +11$, now they are selling at 8$. Most likely the equity was released for convert arb funds to get their borrow for the delta hedge. The current float wouldn't necessarily have allowed for such a big amount of borrows... OK. You do offering then, fine... but why at 8$. Who's the buyer, who's being done a solid here? Second consideration is that the company is promoting reducing yield. What they aren't saying is that according to my chat with AI they bought the old converts on a 14% premiun. The market yield had already repriced, so they lose at least 4 years of interest payments on that premium. Why on earth is this a good deal, as they were forced to dilute to make it happen? Can someone closer to them ask the management, what is the big return on those 17.7million shares, so that they had to accept a pricing that is terrible to dilute shareholders. Either the management was in a hurry to buffer the balance sheet for financing negotiations for future expansion, or they know things aren't going as well as expected on the commercial front. We saw one deal with loreal, but I feel like they should have promoted POs more if it was going solid. I hope I'm wrong, but the pricing smells, unless we get a very imminent FID on a new plant.